Leukemia clinical trials in New York
26 studies for Leukemia are looking for participants at sites in New York.
Cities in New York
- New York City19 studies
- Queens8 studies
- Buffalo7 studies
- Staten Island4 studies
- New Rochelle4 studies
- Rochester4 studies
- Greenburgh3 studies
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 4, Buffalo
- Quetzal Site 2, The Bronx
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Weill Cornell, New York
- Clinical Research Allicance, Westbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06824168A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Montefiore Medical Center, New York
RecruitingPhase 1/2
30 Days · All sexes · Updated Sep 16, 2026 · NCT04065399A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 11, 2026 · NCT06229912Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Rochester
RecruitingPhase 3
Ages 18 to 18 · All sexes · Updated Sep 8, 2026 · NCT07509151Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Columbia University Medical Center New York Presbyterian, New York
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 2, 2026 · NCT07354074First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07586618Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Roswell Park Comprehensive Cancer Center, Buffalo
- Northwell Health, LLC PRIME, Lake Success
- Memorial Sloan Kettering Cancer Center, New York
- and 3 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- State University of New York at Buffalo, Buffalo
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Research Site, New York
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Aug 19, 2026 · NCT06137118Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- New York Medical College, Valhalla
RecruitingPhase 1/2
Ages 13 to 90 · All sexes · Updated Aug 6, 2026 · NCT06533579Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Albany Medical Center, Albany
RecruitingObservational study
Up to age 30 · All sexes · Updated Jul 16, 2026 · NCT04968834Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443Hairy Cell Leukemia Patient Data Registry
- University of Rochester /Wilmot Cancer Institute, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT02560883Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699CD4CAR for CD4+ Leukemia and Lymphoma
- Albert Einstein Health Network, New York
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Jun 24, 2026 · NCT03829540A Study of Revumenib and Mezigdomide in People With Leukemia
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Jun 22, 2026 · NCT07356154A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05475925A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- and 1 more
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated May 26, 2026 · NCT07052916Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 2
Up to age 26 · All sexes · Updated May 14, 2026 · NCT07566377A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York University Langone Hospital - Long Island, Mineola
- Perlmutter Cancer Center - 34th Street, New York
- and 2 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York - Presbyterian / Weill Cornell Medicine, New York
- Mount Sinai - Ruttenberg Treatment Center, New York
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jan 23, 2026 · NCT00582621SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT06501196From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.